vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Westrock Coffee Co (WEST). Click either name above to swap in a different company.
CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $339.5M, roughly 1.4× Westrock Coffee Co). Westrock Coffee Co runs the higher net margin — -6.6% vs -10.1%, a 3.5% gap on every dollar of revenue. On growth, Westrock Coffee Co posted the faster year-over-year revenue change (48.3% vs 44.7%). Westrock Coffee Co produced more free cash flow last quarter ($27.8M vs $-69.0M). Over the past eight quarters, Westrock Coffee Co's revenue compounded faster (32.8% CAGR vs 18.6%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
Westrock Coffee Co is a global integrated coffee, tea and functional beverage solutions provider. It sources, roasts, manufactures and distributes coffee products, ready-to-drink beverages and custom formulations for retail, foodservice and commercial clients across North America and other key markets.
CLOV vs WEST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $487.7M | $339.5M |
| Net Profit | $-49.3M | $-22.6M |
| Gross Margin | — | 11.5% |
| Operating Margin | -10.1% | -2.6% |
| Net Margin | -10.1% | -6.6% |
| Revenue YoY | 44.7% | 48.3% |
| Net Profit YoY | -123.2% | 8.3% |
| EPS (diluted) | — | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $487.7M | $339.5M | ||
| Q3 25 | $496.6M | $354.8M | ||
| Q2 25 | $477.6M | $280.9M | ||
| Q1 25 | $462.3M | $213.8M | ||
| Q4 24 | $337.0M | $229.0M | ||
| Q3 24 | $331.0M | $220.9M | ||
| Q2 24 | $356.3M | $208.4M | ||
| Q1 24 | $346.9M | $192.5M |
| Q4 25 | $-49.3M | $-22.6M | ||
| Q3 25 | $-24.4M | $-19.1M | ||
| Q2 25 | $-10.6M | $-21.6M | ||
| Q1 25 | $-1.3M | $-27.2M | ||
| Q4 24 | $-22.1M | $-24.6M | ||
| Q3 24 | $-9.2M | $-14.3M | ||
| Q2 24 | $7.4M | $-17.8M | ||
| Q1 24 | $-19.2M | $-23.7M |
| Q4 25 | — | 11.5% | ||
| Q3 25 | — | 11.7% | ||
| Q2 25 | — | 14.7% | ||
| Q1 25 | — | 13.6% | ||
| Q4 24 | — | 16.6% | ||
| Q3 24 | 24.5% | 16.8% | ||
| Q2 24 | 30.3% | 19.9% | ||
| Q1 24 | 23.6% | 19.4% |
| Q4 25 | -10.1% | -2.6% | ||
| Q3 25 | -4.9% | -2.4% | ||
| Q2 25 | -2.2% | -5.3% | ||
| Q1 25 | -0.3% | -6.1% | ||
| Q4 24 | -6.4% | -4.3% | ||
| Q3 24 | -2.7% | -5.8% | ||
| Q2 24 | 2.0% | -7.9% | ||
| Q1 24 | -6.5% | -5.3% |
| Q4 25 | -10.1% | -6.6% | ||
| Q3 25 | -4.9% | -5.4% | ||
| Q2 25 | -2.2% | -7.7% | ||
| Q1 25 | -0.3% | -12.7% | ||
| Q4 24 | -6.6% | -10.7% | ||
| Q3 24 | -2.8% | -6.5% | ||
| Q2 24 | 2.1% | -8.5% | ||
| Q1 24 | -5.5% | -12.3% |
| Q4 25 | — | $-0.22 | ||
| Q3 25 | — | $-0.20 | ||
| Q2 25 | — | $-0.23 | ||
| Q1 25 | — | $-0.29 | ||
| Q4 24 | — | $-0.26 | ||
| Q3 24 | — | $-0.16 | ||
| Q2 24 | — | $-0.20 | ||
| Q1 24 | — | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.3M | $49.9M |
| Total DebtLower is stronger | — | $444.1M |
| Stockholders' EquityBook value | $308.7M | $-1.9M |
| Total Assets | $541.0M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.3M | $49.9M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $44.0M | ||
| Q1 25 | — | $33.1M | ||
| Q4 24 | $194.5M | $26.2M | ||
| Q3 24 | $288.0M | $22.4M | ||
| Q2 24 | $254.8M | $24.3M | ||
| Q1 24 | $208.3M | $12.6M |
| Q4 25 | — | $444.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $393.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $308.7M | $-1.9M | ||
| Q3 25 | $340.9M | $11.4M | ||
| Q2 25 | $344.2M | $18.2M | ||
| Q1 25 | $336.1M | $71.4M | ||
| Q4 24 | $341.1M | $97.5M | ||
| Q3 24 | $342.2M | $110.3M | ||
| Q2 24 | $324.9M | $81.5M | ||
| Q1 24 | $292.5M | $91.7M |
| Q4 25 | $541.0M | $1.2B | ||
| Q3 25 | $559.7M | $1.2B | ||
| Q2 25 | $575.0M | $1.2B | ||
| Q1 25 | $583.7M | $1.1B | ||
| Q4 24 | $580.7M | $1.1B | ||
| Q3 24 | $653.0M | $1.1B | ||
| Q2 24 | $674.2M | $1.1B | ||
| Q1 24 | $671.8M | $983.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.03× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-66.9M | $36.7M |
| Free Cash FlowOCF − Capex | $-69.0M | $27.8M |
| FCF MarginFCF / Revenue | -14.1% | 8.2% |
| Capex IntensityCapex / Revenue | 0.4% | 2.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-69.2M | $-107.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-66.9M | $36.7M | ||
| Q3 25 | $12.1M | $-26.6M | ||
| Q2 25 | $5.4M | $-7.0M | ||
| Q1 25 | $-16.3M | $-22.1M | ||
| Q4 24 | $34.8M | $2.8M | ||
| Q3 24 | $50.0M | $-332.0K | ||
| Q2 24 | $44.8M | $-23.7M | ||
| Q1 24 | $25.9M | $8.0M |
| Q4 25 | $-69.0M | $27.8M | ||
| Q3 25 | $11.4M | $-44.7M | ||
| Q2 25 | $4.8M | $-27.5M | ||
| Q1 25 | $-16.5M | $-63.4M | ||
| Q4 24 | $33.3M | $-15.4M | ||
| Q3 24 | $49.6M | $-36.7M | ||
| Q2 24 | $44.4M | $-59.9M | ||
| Q1 24 | $25.5M | $-60.9M |
| Q4 25 | -14.1% | 8.2% | ||
| Q3 25 | 2.3% | -12.6% | ||
| Q2 25 | 1.0% | -9.8% | ||
| Q1 25 | -3.6% | -29.7% | ||
| Q4 24 | 9.9% | -6.7% | ||
| Q3 24 | 15.0% | -16.6% | ||
| Q2 24 | 12.5% | -28.7% | ||
| Q1 24 | 7.3% | -31.7% |
| Q4 25 | 0.4% | 2.6% | ||
| Q3 25 | 0.1% | 5.1% | ||
| Q2 25 | 0.1% | 7.3% | ||
| Q1 25 | 0.0% | 19.3% | ||
| Q4 24 | 0.5% | 7.9% | ||
| Q3 24 | 0.1% | 16.5% | ||
| Q2 24 | 0.1% | 17.4% | ||
| Q1 24 | 0.1% | 35.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 6.04× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLOV
Segment breakdown not available.
WEST
| Coffee And Tea | $202.6M | 60% |
| Flavors Extracts And Ingredients | $69.6M | 21% |
| Sustainable Sourcing And Traceability Segments | $66.9M | 20% |
